Microvascular complications of impaired glucose tolerance.

scientific article published on December 2003

Microvascular complications of impaired glucose tolerance. is …
instance of (P31):
scholarly articleQ13442814
review articleQ7318358

External links are
P356DOI10.2337/DIABETES.52.12.2867
P698PubMed publication ID14633845
P5875ResearchGate publication ID8994210

P50authorJ Robinson SingletonQ125193891
Eva FeldmanQ5415042
P2093author name stringJames W Russell
A Gordon Smith
P433issue12
P407language of work or nameEnglishQ1860
P921main subjectmicrovesselQ6840468
P1104number of pages7
P304page(s)2867-2873
P577publication date2003-12-01
P1433published inDiabetesQ895262
P1476titleMicrovascular complications of impaired glucose tolerance
P478volume52

Reverse relations

cites work (P2860)
Q9296716730-days effects of vildagliptin on vascular function, plasma viscosity, inflammation, oxidative stress, and intestinal peptides on drug-naïve women with diabetes and obesity: a randomized head-to-head metformin-controlled study
Q37890777A new approach to glucose control in type 2 diabetes: the role of kidney sodium-glucose co-transporter 2 inhibition
Q35543708A novel animal model of impaired glucose tolerance induced by the interaction of vitamin E deficiency and (60)Co radiation.
Q36424947A very low carbohydrate ketogenic diet prevents the progression of hepatic steatosis caused by hyperglycemia in a juvenile obese mouse model
Q37385924A1C predicts type 2 diabetes and impaired glucose tolerance in a population at risk: the community diabetes prevention project
Q42073600Adiponectin deficiency increases leukocyte-endothelium interactions via upregulation of endothelial cell adhesion molecules in vivo
Q57246124Alterations in liver sinusoidal endothelium in a baboon model of type 1 diabetes
Q42918336American College Of Endocrinology Pre-Diabetes Consensus Conference: part one.
Q35691890Anthrax lethal toxin suppresses high glucose induced VEGF over secretion through a post-translational mechanism
Q39009713Aptamers: novel diagnostic and therapeutic tools for diabetes mellitus and metabolic diseases.
Q28390982Aryl hydrocarbon receptor is activated by glucose and regulates the thrombospondin-1 gene promoter in endothelial cells
Q36727665Association of Pro12Ala polymorphism in peroxisome proliferator activated receptor gamma with proliferative diabetic retinopathy
Q36593020Biomarkers of body iron stores and risk of developing type 2 diabetes
Q38916549Biphasic effect of Solanum nigrum fruit aqueous extract on vascular mesenteric beds in non-diabetic and streptozotocin-induced diabetic rats.
Q46891955Blood glucose and cerebrovascular disease in nondiabetic patients
Q37379519Body mass index is associated with increased creatinine clearance by a mechanism independent of body fat distribution
Q36939649Cardiovascular disease and type 2 diabetes mellitus: a multifaceted symbiosis
Q36152839Characterisation of morbidity in a UK, hospital based, obesity clinic.
Q57922118Childhood Obesity and Insulin Resistance: How Should It Be Managed?
Q58700390Circulating microRNAs -192 and -194 are associated with the presence and incidence of diabetes mellitus
Q33610749Combined pharmacologic/nonpharmacologic intervention in individuals at high risk of developing type 2 diabetes: pro pharmacologic therapy
Q51297171Comparison of echocardiographic findings with laboratory parameters in obese children.
Q40353553Constant and intermittent high glucose enhances endothelial cell apoptosis through mitochondrial superoxide overproduction
Q35881459Corneal Confocal Microscopy Identifies Small-Fiber Neuropathy in Subjects With Impaired Glucose Tolerance Who Develop Type 2 Diabetes
Q50328302Cutaneous manifestations of diabetic peripheral neuropathy
Q38360974Dapagliflozin: a new sodium-glucose cotransporter 2 inhibitor for treatment of type 2 diabetes
Q46011073Determination of nerve conduction abnormalities in patients with impaired glucose tolerance.
Q85728487Diabetic neuropathies
Q33554384Diabetic neuropathy: mechanisms to management
Q37893102Diabetic polyneuropathies: update on research definition, diagnostic criteria and estimation of severity
Q46099822Diabetic retinopathy is associated with insulin resistance and cardiovascular autonomic dysfunction in type 2 diabetic patients
Q39133016Differential inhibition by hyperglycaemia of shear stress- but not acetylcholine-mediated dilatation in the iliac artery of the anaesthetized pig.
Q35761602Do retinopathy signs in non-diabetic individuals predict the subsequent risk of diabetes?
Q47937998Dysregulation of Calpain Proteolytic Systems Underlies Degenerative Vascular Disorders
Q27332290Early Cellular Changes in the Ascending Aorta and Myocardium in a Swine Model of Metabolic Syndrome
Q34106165Effect of Treatment of Sprague Dawley Rats with AVE7688, Enalapril, or Candoxatril on Diet-Induced Obesity
Q87683460Elevated neurofilament light chain (NFL) mRNA levels in prediabetic peripheral neuropathy
Q38712728Empagliflozin Improves Left Ventricular Diastolic Dysfunction in a Genetic Model of Type 2 Diabetes.
Q89604879Enhanced oral bioavailability and anti-diabetic activity of canagliflozin through a spray dried lipid based oral delivery: a novel paradigm
Q46476732Evaluation of peripheral and autonomic neuropathy among patients with newly diagnosed impaired glucose tolerance
Q34024860Exercise and type 2 diabetes: the American College of Sports Medicine and the American Diabetes Association: joint position statement
Q38625575Exercise as Therapy for Diabetic and Prediabetic Neuropathy.
Q39626888FOXO1 plays an essential role in apoptosis of retinal pericytes
Q34580862Genome-wide association study of retinopathy in individuals without diabetes
Q36232157Glucose tolerance status is a better predictor of diabetes and cardiovascular outcomes than metabolic syndrome: a prospective cohort study
Q51391547HISS, not insulin, causes vasodilation in response to administered insulin
Q55026843Hemorheologic Alterations in Patients with Type 2 Diabetes Mellitus Presented with an Acute Myocardial Infarction.
Q33577717Hexosamine pathway but not interstitial changes mediates glucotoxicity in pancreatic β-cells as assessed by cytosolic Ca2+ response to glucose
Q64121781High glucose level and angiotensin II type 1 receptor stimulation synergistically amplify oxidative stress in renal mesangial cells
Q96304963Hyperinsulinemia contributes to impaired-glucose-tolerance-induced renal injury via mir-7977/SIRT3 signaling
Q35691372IMproving the imPlemEntation of cuRrent guidelines for the mAnagement of major coronary hearT disease rIsk factors by multifactorial interVEntion. The IMPERATIVE renal analysis
Q36957155Idiopathic neuropathy patients are at high risk for metabolic syndrome
Q34238965Impact of diabetes and peripheral arterial occlusive disease on the functional microcirculation at the plantar foot
Q43215429Impaired glucose tolerance and endothelial damage, as assessed by levels of von Willebrand factor and circulating endothelial cells, following acute myocardial infarction
Q38006758Impaired glucose tolerance and metabolic syndrome in idiopathic neuropathy
Q101574248Incidence and risk factors of vascular complications in people with impaired fasting glucose: a national cohort study in Korea
Q47436179Individuals with impaired glucose tolerance demonstrate normal cardiac sympathetic innervation using I-123 mIBG scintigraphy
Q38338557Insulin resistance does not diminish eNOS expression, phosphorylation, or binding to HSP-90.
Q51366750Insulin resistance increases risk of carpal tunnel syndrome: a case-control study.
Q38488715Insulin resistance is independently associated with peripheral and autonomic neuropathy in Korean type 2 diabetic patients
Q46581854Insulin-like growth factor-binding protein-1 in the prediction and development of type 2 diabetes in middle-aged Swedish men.
Q79308138Insulin-status-dependent modulation of FoF1-ATPase activity in rat liver mitochondria
Q43044546Intermittent high glucose enhances cell proliferation and VEGF expression in retinal endothelial cells: the role of mitochondrial reactive oxygen species
Q51368824Intramuscular injection of soluble receptor for advanced glycation endproducts expression vector prevents the development of streptozotocin-induced diabetes mellitus in rats on high fat diet.
Q37967126Is there a divergence in time trends in the prevalence of impaired glucose tolerance and diabetes? A systematic review in South Asian populations.
Q37125726Is vaspin related to cardio-metabolic status and autonomic function in early stages of glucose intolerance and in metabolic syndrome?
Q38086281Lifestyle impact on meal-induced insulin sensitization in health and prediabetes: a focus on diet, antioxidants, and exercise interventions
Q33729970Long-lasting effect of obesity on skeletal muscle transcriptome
Q35584332Maternal salt and fat intake causes hypertension and sustained endothelial dysfunction in fetal, weanling and adult male resistance vessels.
Q36012896Metabolic effects of the incretin mimetic exenatide in the treatment of type 2 diabetes
Q46801064Metabolic syndrome increases endogenous carbon monoxide production to promote hypertension and endothelial dysfunction in obese Zucker rats
Q51310417Metformin and its effects on myocardial dimension and left ventricular hypertrophy in normotensive patients with coronary heart disease (the MET-REMODEL study): rationale and design of the MET-REMODEL study.
Q36206352Microvascular Blood Flow Improvement in Hyperglycemic Obese Adult Patients by Hypocaloric Diet
Q37579758Microvascular dysfunction in diabetic foot disease and ulceration.
Q50459619Morphological restructuring of myocardium during the early phase of experimental diabetes mellitus
Q35790594Myocardin-Related Transcription Factor A Epigenetically Regulates Renal Fibrosis in Diabetic Nephropathy
Q37792183Neuropathy and impaired glucose tolerance: an updated review of the evidence
Q37900473Neuropathy in prediabetes: does the clock start ticking early?
Q35071239Neurovascular interaction and the pathophysiology of diabetic retinopathy
Q33226200Non-invasive methods and stimuli for evaluating the skin's microcirculation.
Q35225416One-hour postload plasma glucose levels and diastolic function in hypertensive patients
Q35043292One-hour postload plasma glucose levels and left ventricular mass in hypertensive patients
Q43269412Overproduction of phosphoprotein enriched in diabetes (PED) induces mesangial expansion and upregulates protein kinase C-beta activity and TGF-beta1 expression.
Q36755721Oxidative injury and neuropathy in diabetes and impaired glucose tolerance.
Q35060261Peripheral vascular disease and peripheral neuropathy in individuals with cardiometabolic clustering and obesity: National Health and Nutrition Examination Survey 2001-2004.
Q37618185Physical therapy in the 21st century (Part I): toward practice informed by epidemiology and the crisis of lifestyle conditions
Q34188567Pilot study for the evaluation of morphological and functional changes in retinal blood flow in patients with insulin resistance and/or type 2 diabetes mellitus
Q79999725Postprandial hyperglycemia alters inflammatory and hemostatic parameters
Q45004937Potential antidiabetic effect of the Semecarpus anacardium in a type 2 diabetic rat model
Q35390236Prediabetes as a Therapeutic Target
Q46962040Predicting glucose intolerance with normal fasting plasma glucose by the components of the metabolic syndrome
Q35975347Preoperative hyperglycemia and complication risk following neurosurgical intervention: A study of 918 consecutive cases
Q36624270Prevalence of undiagnosed diabetes and pre-diabetes among hypertensive patients attending Kiambu district Hospital, Kenya: a cross-sectional study
Q44091100Prevalence-dependent decision limits for the early detection of type 2 diabetes mellitus in venous blood, venous plasma and capillary blood during glucose challenge
Q38442040Recent advances in glucose-lowering treatment to reduce diabetic kidney disease.
Q35574984Reliability of quantitative sudomotor axon reflex testing and quantitative sensory testing in neuropathy of impaired glucose regulation.
Q48121111Retinal Photoreceptors and Microvascular Changes in Prediabetes Measured with Adaptive Optics (rtx1™): A Case-Control Study.
Q37122850Retinal not systemic oxidative and inflammatory stress correlated with VEGF expression in rodent models of insulin resistance and diabetes
Q92354662Sarcopenia and type 2 diabetes mellitus: a bidirectional relationship
Q37882225Screening for type 2 diabetes and dysglycemia
Q36589206Serial anthropometry predicts peripheral nerve dysfunction in a community cohort
Q44869345Short-term peaks in glucose promote renal fibrogenesis independently of total glucose exposure.
Q36366062Skin microvascular endothelial dysfunction is associated with type 2 diabetes independently of microalbuminuria and arterial stiffness.
Q38086816Sodium-glucose cotransporter inhibition: therapeutic potential for the treatment of type 2 diabetes mellitus
Q37587674Soluble urokinase receptor (suPAR) predicts microalbuminuria in patients at risk for type 2 diabetes mellitus
Q37249319Standing balance and trunk position sense in impaired glucose tolerance (IGT)-related peripheral neuropathy
Q55669037Systematic review and meta-analysis of the effect of SGLT-2 inhibitors on microvascular outcomes in patients with type 2 diabetes: a review protocol.
Q34391710TOR-centric view on insulin resistance and diabetic complications: perspective for endocrinologists and gerontologists
Q35155923The "lipid accumulation product" is associated with 2-hour postload glucose outcomes in overweight/obese subjects with nondiabetic fasting glucose
Q48053758The effect of high-dose vitamin D3 supplementation on bone mineral density in subjects with prediabetes
Q36577293Therapy insight: neurological complications of prediabetes
Q33393882Treatment of diabetic sensory polyneuropathy
Q53173104Variables associated with corneal confocal microscopy parameters in healthy volunteers: implications for diabetic neuropathy screening.
Q34965730Within-visit blood pressure variability is associated with prediabetes and diabetes
Q51352541[Prediabetes: diagnosis, evaluation of chronic complications, and treatment].

Search more.